NCT01784640
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Jonsson Comprehensive Cancer Center Los Angeles, California, United States
Clinical trial condition
Lung Neoplasms
Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.
4,227 public trials
1,016 recruiting studies
Lung Neoplasms trial results
NCT04076228
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Kiang Wu Hospital Macao, China
NCT02364804
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Shiga University of Medical Science Hospital Ōtsu, Shiga, Japan
NCT03450330
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- St George Hospital Sydney, New South Wales, Australia
- Austin Hospital Heidelberg, Victoria, Australia
- Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
- Northern Cancer Institute St Leonards Sydney, Australia
NCT02499770
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
- Locations
-
- Genesis Cancer Center Hot Springs, Arkansas, United States
- Highlands Oncology Group Rogers, Arkansas, United States
- The Oncology Institute of Hope and Innovation Whittier, California, United States
- Memorial Hospital - Univ. of Colorado Health Colorado Springs, Colorado, United States
Completed
A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung
NCT01218516
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of the Lung, +8 more
- Locations
-
- Ironwood Cancer and Research Center Chandler, Arizona, United States
- Arizona Center for Hematology Oncology Glendale, Arizona, United States
- Providence Health System Beverly Hills, California, United States
- Cancer Care Associates of Fresno Medical Group, Inc. Fresno, California, United States
Completed
Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors
NCT02658214
- Conditions
- Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +58 more
- Locations
-
- Research Site Chūōku, Japan
- Research Site Kashiwa, Japan
- Research Site Seoul, South Korea
- Research Site Seoul, South Korea
NCT02492568
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
- Locations
-
- Antoni van Leeuwenhoek (NKI-AVL) Amsterdam, North Holland, Netherlands
NCT02983500
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
- Locations
-
- Multiple sites all over Germany Multiple Locations, Germany
Completed
Bortezomib in KRAS-Mutant Non-Small Cell Lung Cancer in Never Smokers or Those With KRAS G12D
NCT01833143
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- Memorial Sloan Kettering Cancer Center at Mercy Medical Center Rockville Centre, New York, United States